$XBI -0.60% $133.58
Covid Updates
$AZN +0.03% AstraZeneca welcomes Court ruling on supply of its COVID-19 vaccine to Europe. source
Pipeline Updates
$ORPH -49.66% Orphazyme provides regulatory update from FDA on arimoclomol for Niemann-Pick disease type C. source
$TGTX -0.77% TG Therapeutics Announces Presentation of Data from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis at 7th Congress of the European Academy of Neurology. source
$SRRK +0.52% Scholar Rock to Present Apitegromab TOPAZ Phase 2 Trial Results Highlighting Pharmacokinetic (PK) and Pharmacodynamic (PD) Data at the 2021 European Academy of Neurology Congress. source
$TGTX -0.77% TG Therapeutics Announces Preclinical and Clinical Data Evaluating TG-1701 at the 16th International Congress on Malignant Lymphoma. source
$ADCT +1.09% ADC Therapeutics Presents Updated ZYNLONTA™ (loncastuximab tesirine-lpyl) Clinical Data at 16th Annual International Conference on Malignant Lymphoma. source
$ISEE -0.17% Iveric Bio to Present Zimura® GATHER2 Enrollment and Retention Updates and New GATHER1 Post-Hoc Analyses Today at its Dry Age-Related Macular Degeneration Virtual Symposium for Investors. source
$BNTX -0.83% BioNTech Announces First Patient Dosed in Phase 2 Clinical Trial of mRNA-based BNT111 in Patients with Advanced Melanoma. source
Financial Updates
$RAPT +3.50% RAPT Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares. source
$PTGX -1.55% Protagonist Therapeutics, Inc. Announces Closing of $132.2 Million Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares source
Posted by MV
Comentários